[논문]당뇨 환자의 체중감량을 위한 가미태음조위탕의 임상적 활용: 후향적 차트 리뷰

이아름; 이다연; 김민지; 이향숙; 최가혜; 김서영; 임영우; 박영배

doi:10.13048/jkm.21004

당뇨 환자의 체중감량을 위한 가미태음조위탕의 임상적 활용: 후향적 차트 리뷰
Gamitaeeumjowee-Tang for weight loss in diabetic patients: A retrospective chart review 원문보기

Journal of Korean Medicine = 대한한의학회지, v.42 no.1, 2021년, pp.46 - 58

이아름 (경희대학교 대학원 한의과대학 경락의과학과) , 이다연 (누베베 한의원) , 김민지 (누베베 한의원) , 이향숙 (경희대학교 대학원 한의과대학 경락의과학과) , 최가혜 (누베베 한의원) , 김서영 (누베베 한의원) , 임영우 (누베베 한의원) , 박영배 (누베베 미병 연구소)

Abstract ▼ AI-Helper

Objectives: The purpose of this study is to report weight changes and analyze adverse events in diabetic patients with Gamitaeeumjowee-Tang for weight loss. Methods: A retrospective chart review of weight change and adverse events was performed during the 10-week weight loss program using Gamitaeeumjowee-tang with low-calorie diets for diabetics(n=61). Weight and BMI changes were compared before and after the program and calculated the percentage of people who lost more than 5% of their weight, also identified whether subjects felt satiated or not. Adverse events were evaluated in terms of causality, severity and system-organ classes. Results: After 10-week weight loss program, significant weight loss (5.9±2.32kg, 7.73% reduction from baseline) and BMI reduction (2.9±0.86) were reported (n=61). Those who lost more than 5 percent of their body weight accounted for 88.5%, and also 88.5% of the participants felt full to help control their appetite. In assessing the causality of adverse events, 'Unlikely' was the most common (66%) and in severity evaluations, almost all symptoms were mild. Insomnia was the most frequently reported during the first 8 weeks, and constipation was reported the most afterwards. Conclusions: A combination of Gamitaeeumjowee-tang and low-calorie diets for 10 weeks appears to help weight reduction without serious adverse events in diabetic patients. Future well-designed prospective clinical studies testing the effectiveness and safety of this weight loss program are warranted.

주제어

표/그림 (9)

표 Table 1. Exclusion Criteria for Prescription
그림 Fig. 1. Study patients flowchart
표 Table 2. Composition of Gamitaeeumjowee-Tang
표 Table 3. Baseline Characteristics of 61 Subjects
표 Table 4. Medical Records and Medication of 61 Subjects
표 Table 5. Change of Weight and Body Mass Index for 10 weeks for 61 subjects
표 Table 6. Adverse Events Reported from 61 Patients on Weight Loss Program using Gamitaeeumjowee-tang
그림 Fig. 2. Weight change from baseline
표 Table 7. Adverse Events According to System Organ Classes

참고문헌 (39)

Korean Diabetes Association. Treatment Guideline for Diabetes. 2018;13,17.
Jang HC, Choi SH. Characterization of Patients with Type 2 Diabetes according to Body Mass Index: Korea National Health and Nutrition Examination Survey from 2007 to 2011. Endocrinol Metab. 2015;30:514-21.

상세보기
Korean Obesity Association. Treatment Guideline for Obesity.2018;17-18.
Korean Diabetes Association. Diabetes Fact Sheet. 2018.
Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-61.

상세보기
Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011; 34:1481-6.

상세보기
Kim DH, Park SC, Lee JH, Lee HY, Cho MK, Cho JYi, et al. Recent Research Trends in Korean Medicine Treatment of Diabetes Mellitus - Focusing on Domestic Articles from 2008 to 2013 -. Korean J Orient Int Med. 2013;4(3):240-55.
Hanefeld M, Fischer S, Schmechel H, Rothe G, Schulze J, Dude H, et al. Diabetes Intervention Study, Multi-intervention trial in newly diagnosed NIDDM. Diabetes Care. 1991;14: 308-17.

상세보기
United Kingdom Prospective Diabetes Study (UK-PDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ. 1995;310:83-8.

상세보기
Lee MJ, Kim SS. Management of Obesity in Patients with Diabetes Mellitus. J Korean Diabetes, 2017;18:229-38,

상세보기
Chon S, Park CY, Koh GP, Oh SJ, Woo JT, Kim SW et al. The Effect of Orlistat in Obese Patients with Type 2 Diabetes : Benefit on Abdominal Obesity and Glycemic Control. J Korean Med Obes Res. 2004;13(4):281-92.
Lee EJ, Kim TN. Pharmacological Management of Obesity in Patients with Type 2 Diabetes: An Update. Korean J Obes. 2016;25(3):121-8.

상세보기
O'Neil PM, Smith SR, Weissman NJ, Fidler MC, Sanchez M, Zhang J, et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity. 2012;20:1426-36.

상세보기
Hollander P, Gupta AK, Plodkowski R, Greenway F, Bays H, Burns C, et al. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013;36:4022-9.

상세보기
Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjoth TV, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial. JAMA. 2015;314:687-99.

상세보기
Han HJ, Kim HJ, Park EY, Jang JA, An TH, Seo HS , et al. The effect of oriental obesity therapy on Morbid obese patient with Type 2 Diabetes : Two Cases Report. J Korean Med. 2010;10:57-63.
Kim HJ, Kim KS. Improvement of type 2 diabetes by very-low-calorie diet-A case report. J Korean Med. 2002;2(1):97-102.
Cha YY. A case Study on the Treatment of Obese patient with diabetes. J Korean Med. 2004;4(1):193-9.
World Health Organization-Uppsala Monitoring Centre (WHO-UMC). Causality categories [Internet]. Uppsala (Sweden): World Health Organization-Uppsala Monitoring Centre (WHO-UMC); 2018. [cited 2012 Oct 22]. Available from: https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf.
Korea Institute of Drug Safety & Risk Management. Adverse Drug Reaction Assessment Report. 1st ed. Seoul : Korea Institute of Drug Safety & Risk Management. 2013:60-3.
National Cancer Institute. National Institute of Health. U.S.DEPARTMENT OF HEALTH AND HUMAN SERVICES. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. 2010.
Basch E, Reeve B, Mitchell S, Clauser S, Minasian L, Dueck A, et al. Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). 2014;106(9):244.
Korea Institute of Drug Safety & Risk Management. Terminology Guide for Reporting Adverse Drug Reactions. Seoul : Korea Institute of Drug Safety & Risk Management. 2014:1-6.
Lee JM. Longevity and life preservation in Eastern medicine, Seoul : Haklimsa. 1986;333-8.
Lee JE, Song YK, Lim HH. Clinical trial of Taeeumjowui-tang (Taiyintiaowei-tang) on obese patients: randomized, double blind, placebo-controlled study. J Orient Rehab Med. 2010;20(4):197-213.
Lim SY, Park SW, Joo JH, Kim SR, Kim DJ, Choi WS. The effects of Taeeumjowui-tang (Taiyintiaowei-tang) on obesity in Sasang constitution. J East-West Med. 2012;37(4):109-16.
Park SJ, Nahmkoong W, Cheon CH, Park JS, Jang BH, Shin YC, et al. Efficacy and safety of Taeeumjowi-tang in obese Korean adults: a double-blind, randomized, and placebo-controlled pilot trial. Evid-Based Complement Altern Med. 2013;2013:498935.
Hwang MJ, Shin HD, Song MY. Literature review of herbal medicines on treatment of obesity since 2000; mainly about Ephedra Herba. J Korean Med Obes Res. 2007;7(1):39-54.
Jang IS, Hwang EH. The Need for Clinical Practice Guidelines in Usage of Mahuang in Weight Loss. J Korean Med Obes Res. 2007;(1):23-9.
Jo GW, OK JM, Kim SY, Lim YW. Review on the efficacy and safety of Mahuang and ephedrine in the treatment of obesity-focused on RCT. J Korean Med. 2017;38(3):170-84.

원문보기 상세보기
Wing RR, Marcus MD, Epstein LH, Jawad A. A "family-based" approach to the treatment of of obese Type II diabetic patients. J Consult Clin Psychol. 1991;59:156-62.

상세보기
Yoon NR, Yoo YJ, Kim MJ, Kim SY, Lim YW, Lim HH et al. Analysis of Adverse Events in Weight Loss Program in Combination with 'Gamitaeeumjowee-Tang' and Low-Calorie Diet. J Korean Med Obes Res. 2018;18(1):1-9.

원문보기 상세보기
Kim HJ, Kim JY. Clinical report about the adverse reactions of Taeeumin.Soeumin.Soyangin by Taeeumjowi-tang. Korean J Oriental Physiology & Pathology. 2008;22(6):1600-5.
Luyster FS, Dunbar-Jacob J. Sleep quality and quality of life in adults with type 2 diabetes. Diabetes Educ. 2011;379:347-55.

상세보기
Jain A, Sharmab R, Yadavc N, Chaudhary P, Jainc G, Maanju M. Quality of life and its association with insomnia and clinical variables in type 2 diabetes. J Egypt Public Health Assoc. 2017;92(1):52-9.

상세보기
Attarian H, Hachul H, Guttuso T, Phillips B. Treatment of chronic insomnia disorder in menopause: Evaluation of literature. Menopause. 2015;22(6):674-84.

상세보기
Hwa Kim. Diagnosis and Management of Diabetic Autonomic Neuropathy Chong. J Korean Diabetes. 2018;19:160-7.

상세보기
Christensen P, Bliddal H, Riecke BF, Leeds AR, Astrup A, Christensen R. Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomized controlled trial. Clin Obes. 2011;1(1):31-4.

상세보기
Kim JS, Yoon SH. Effect of Naesosan gastric motility between normal intact and antral dilatated rats. J Korean Orient Int Med. 2008;29(1):117-129.

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증